Literature DB >> 8755654

The role of vascular injury and hemodynamics in rat pulmonary artery remodeling.

Y Tanaka1, D P Schuster, E C Davis, G A Patterson, M D Botney.   

Abstract

Vascular remodeling in adult human elastic pulmonary arteries is characterized by diffuse neointimal lesions containing smooth muscle cells expressing extracellular matrix genes. Recent studies suggest vascular injury is needed to initiate remodeling and that growth factor mediators participate in the repair response. However, because neointimal formation is only observed in patients with pulmonary artery blood pressures approaching systemic levels, it has been hypothesized that systemic-like hemodynamic conditions are also necessary. To test that hypothesis, subclavian-pulmonary artery anastomoses were created in Sprague-Dawley rats under three different experimental conditions: no accompanying injury, or after monocrotaline or balloon endarterectomy injury. Pulmonary vascular remodeling was not induced by the subclavian-pulmonary artery anastomosis alone. A non-neointimal pattern of remodeling after mild monocrotaline-induced injury was converted into a neointimal pattern in the presence of the anastomosis. Neointima was also observed after severe, balloon endarterectomy-induced injury even in the absence of anastomosis. Tropoelastin, type I procollagen and TGF-beta gene expression, and angiotensin converting enzyme immunoreactivity, was confined to the neointima resembling the pattern of gene expression and immunoreactivity in human hypertensive elastic pulmonary artery neointimal lesions. These observations introduce the concepts that the type of injury and the associated hemodynamic conditions can modify the elastic pulmonary artery response to injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755654      PMCID: PMC507447          DOI: 10.1172/JCI118809

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury.

Authors:  J Fingerle; Y P Au; A W Clowes; M A Reidy
Journal:  Arteriosclerosis       Date:  1990 Nov-Dec

2.  Collagen and elastin metabolism in hypertensive pulmonary arteries of rats.

Authors:  G J Poiani; C A Tozzi; S E Yohn; R A Pierce; S A Belsky; R A Berg; S Y Yu; S B Deak; D J Riley
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

3.  A new in vitro system for studying cell response to mechanical stimulation. Different effects of cyclic stretching and agitation on smooth muscle cell biosynthesis.

Authors:  D Y Leung; S Glagov; M B Mathews
Journal:  Exp Cell Res       Date:  1977-10-15       Impact factor: 3.905

4.  Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types.

Authors:  V Kolpakov; M D Rekhter; D Gordon; W H Wang; T J Kulik
Journal:  Circ Res       Date:  1995-10       Impact factor: 17.367

5.  Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization.

Authors:  I W Prosser; K R Stenmark; M Suthar; E C Crouch; R P Mecham; W C Parks
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

7.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

8.  Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries.

Authors:  M D Botney; L R Kaiser; J D Cooper; R P Mecham; D Parghi; J Roby; W C Parks
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

9.  Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.

Authors:  K R Stenmark; M L Morganroth; L K Remigio; N F Voelkel; R C Murphy; P M Henson; M M Mathias; J T Reeves
Journal:  Am J Physiol       Date:  1985-06

10.  Pathological changes in rats as a result of treatment with monocrotaline.

Authors:  R SCHOENTAL; M A HEAD
Journal:  Br J Cancer       Date:  1955-03       Impact factor: 7.640

View more
  14 in total

1.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

2.  Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.

Authors:  K Okada; Y Tanaka; M Bernstein; W Zhang; G A Patterson; M D Botney
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 3.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

4.  Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.

Authors:  D Dunbar Ivy; Ivan F McMurtry; Kelley Colvin; Masatoshi Imamura; Masahiko Oka; Dong-Seok Lee; Sarah Gebb; Peter Lloyd Jones
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

5.  Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension.

Authors:  M Patricia George; Hunter C Champion; Marc Simon; Siobhan Guyach; Rebecca Tarantelli; Heather M Kling; Alexandra Brower; Christopher Janssen; Jessica Murphy; Jonathan P Carney; Alison Morris; Mark T Gladwin; Karen A Norris
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

6.  Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.

Authors:  P L Jones; K N Cowan; M Rabinovitch
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

7.  The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Malik Bisserier; Yassine Sassi; Charles R Bridges; Roger J Hajjar; Lahouaria Hadri
Journal:  J Vis Exp       Date:  2019-03-08       Impact factor: 1.355

Review 8.  Vascular remodeling in pulmonary hypertension.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Mol Med (Berl)       Date:  2013-01-19       Impact factor: 4.599

Review 9.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 10.  Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.